Fecal Incontinence: What's Really Going On—and What Helps
The Gastro Girl Podcast
12/16/25
•43m
About
Comments
Featured In
Fecal incontinence (FI) affects nearly 8% of adults worldwide, yet many people suffer in silence due to embarrassment, confusion, or the belief that nothing can be done. This episode is here to change that.
We're joined by Dr. John William Blackett, gastroenterologist and lead author of "Fecal Incontinence in Adults: New Therapies," published in The American Journal of Gastroenterology. Dr. Blackett offers a compassionate, patient-centered overview of FI, including common causes, diagnostic testing, and the full range of treatment options available today—highlighting newer and emerging therapies.
If you've experienced unexpected leakage, urgency, staining, or difficulty controlling bowel movements—or if you support someone who has—this conversation provides clarity, reassurance, and practical guidance. Effective treatments exist, and help is available.
This episode is produced in collaboration with the American College of Gastroenterology Patient Care Committee.
Previous Episode
How Fear Impacts IBS-C and Strategies to Take Control
December 9, 2025
•33m
Living with IBS-C isn't just about managing physical symptoms, it's also about navigating the fear, worry, and emotional toll that often come with the condition. In this powerful episode, host Jacqueline Gaulin is joined by Dr. Sarah Ballou, clinical psychologist and Director of the GI Psychology Service at Beth Israel Deaconess Medical Center, to explore how fear shows up along the IBS-C journey and what you can do to face it with confidence and support.
In this episode, you'll learn:
- The most common fears IBS-C patients experience and how they influence daily life and treatment decisions
- Why fear can sometimes hold you back from finding relief Practical tools to help you feel more in control, confident, and hopeful
- How to talk openly with your provider about the fears that affect your care
Whether you're newly diagnosed or feeling stuck after years of symptoms, this episode offers real-world guidance, emotional validation, and a reminder that you're not alone on this journey.
This episode is sponsored by Ardelyx.
Next Episode
MASH—metabolic dysfunction–associated steatohepatitis (formerly known as NASH)—is a progressive form of fatty liver disease that often develops silently, without obvious symptoms. Many people don't realize their liver is being damaged until the disease has already advanced.
In this episode of the Gastro Girl Podcast, host Jacqueline Gaulin is joined by Dr. Pooja Singhal, a board-certified gastroenterologist, hepatologist, obesity medicine specialist, and founder of the Oklahoma Gastro Health and Wellness Center.
Dr. Singhal explains:
- The difference between MASLD and MASH
- Why MASH is frequently missed or diagnosed late
- Why testing—not symptoms—is the only reliable way to assess liver health
- Who is at risk for developing MASH
- How MASH is diagnosed and what liver testing involves
- Why fibrosis (liver scarring) matters
- Current treatment, prevention, and long-term management strategies
- How early identification can help reduce the risk of cirrhosis and liver cancer
This episode focuses specifically on MASH, the progressive form of fatty liver disease. MASLD is discussed only to help listeners understand how MASH develops and why timely testing matters.
Designed to reduce confusion, raise awareness, and empower patients, this conversation equips listeners with the knowledge they need to have informed discussions with their healthcare providers.
Thank you to Madrigal Pharmaceuticals for supporting this episode.
If you like this episode you’ll love
Promoted